HealthMerck Clears Clinical Trial Milestone, Shows Promise With Alzheimer’s Drug Verubecestat A new drug developed by Merck shows promise for the treatment of Alzheimer’s disease. Verubecestat, which is currently under clinical trial, is said to halt the beta amyloid plaque formation in brain.by Saranya Palanisamy
HealthBeyond A Dessert Topping: Ferrero Seeks Reclassification To Reduce Fat And Calories Per Nutella Servingby Livia Rusu
HealthTaking An Epidural To Ease Labor Pains May Reduce Likelihood Of Postpartum Depression In Some Womenby Saranya Palanisamy
HealthWashington State Couple Facing Charges After Injecting Their Young Children With Heroin As 'Feel Good Medicine'by Livia Rusu
HealthLeapfrog Releases Fall 2016 Hospital Safety Grades, Ranks Hawaii As US State With Safest Hospitalsby Livia Rusu
HealthZika Virus Shrinks Testicles, Reduces Sperm Counts In Mice: Should Men Worry About Infertility Risks?by Saranya Palanisamy
HealthAncient Cholera Strain Likely Present In Haiti Since Colonial Times: Studyby Saranya Palanisamy
HealthSoda Industry Funds Studies That May Mislead Public About Health Effects Of Sweetened Drinksby Rhodi Lee